Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients
Publication: Neurology
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators
8 November 2016